Oculis Holding AG (OCS) Net Cash Flow (2022 - 2026)
Quarterly Net Cash Flow fell 88.82% to $10.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $56.0 million through Mar 2026, down 40.7% year-over-year, with the annual reading at $74.7 million for FY2025, 693.26% up from the prior year.
Oculis Holding AG's Net Cash Flow history spans 5 years, with the latest figure at $10.6 million for Q1 2026.
- Net Cash Flow came in at $10.6 million for Q1 2026, down from $84.5 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $94.4 million in Q1 2025 to a low of -$20.1 million in Q2 2025.
- The 5-year median for Net Cash Flow is -$5.7 million (2022), against an average of $14.7 million.
- Year-over-year, Net Cash Flow crashed 205.76% in 2023 and then skyrocketed 1030.89% in 2025.
- Oculis Holding AG's Net Cash Flow stood at -$8.6 million in 2022, then surged by 219.38% to $10.3 million in 2023, then plummeted by 187.95% to -$9.1 million in 2024, then soared by 1030.89% to $84.5 million in 2025, then tumbled by 87.5% to $10.6 million in 2026.
- Per Business Quant, the three most recent readings for OCS's Net Cash Flow are $10.6 million (Q1 2026), $84.5 million (Q4 2025), and -$18.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -152.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | 10.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.56 Mn |
| Mar 31, 2026 | 10.56 Mn |
| Dec 31, 2025 | 84.47 Mn |
| Dec 31, 2025 | 84.47 Mn |
| Sep 30, 2025 | -18.91 Mn |
| Sep 30, 2025 | -18.91 Mn |
| Jun 30, 2025 | -20.10 Mn |
| Jun 30, 2025 | -20.10 Mn |
| Mar 31, 2025 | 94.39 Mn |
| Mar 31, 2025 | 94.39 Mn |
| Dec 31, 2024 | -9.07 Mn |
| Dec 31, 2024 | -9.07 Mn |
| Sep 30, 2024 | -13.33 Mn |
| Sep 30, 2024 | -13.33 Mn |
| Jun 30, 2024 | 22.47 Mn |
| Jun 30, 2024 | 22.47 Mn |
| Mar 31, 2024 | -17.87 Mn |
| Mar 31, 2024 | -17.87 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Sep 30, 2023 | -17.36 Mn |
| Sep 30, 2023 | -17.36 Mn |
| Jun 30, 2023 | 22.52 Mn |
| Jun 30, 2023 | 22.52 Mn |
| Mar 31, 2023 | 86.12 Mn |
| Mar 31, 2023 | 86.12 Mn |
| Dec 31, 2022 | -8.64 Mn |
| Dec 31, 2022 | -8.64 Mn |
| Sep 30, 2022 | -5.68 Mn |
| Sep 30, 2022 | -5.68 Mn |